Corindus' CorPath GRX Robotic PCI System Approved in Japan


June 8, 2018—Corindus Vascular Robotics, Inc. announced that it received Japan's Pharmaceutical and Medical Device Agency (PMDA) approval for commercialization of its CorPath GRX robotic percutaneous coronary intervention (PCI) system. Additionally, Corindus is pursuing reimbursement for robotic PCI through the Japanese insurance system and plans a postmarket study of CorPath GRX, which is the second generation of the company's CorPath vascular robotic system.

In early 2017, Corindus announced a strategic relationship with Japan Medicalnext Co., Ltd., a wholly owned entity of MC Healthcare, Inc. (a subsidiary of Mitsubishi Corporation), to become the exclusive distributor of Corindus products in Japan.

Takafumi Ueno, MD, commented in the company's press release, "I look forward to offering CorPath GRX to my patients during PCI, especially in complex procedures where precision and procedural control are extremely valuable. We are pleased to be one of the first Asia-Pacific countries to adopt this new and innovative technology." Dr. Ueno is Director of Interventional Cardiology, Center of Cardiovascular Disease, at Kurume University Hospital in Kurume, Fukuoka prefecture, Japan.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.